#q#.# [001]

Related by string. #q#.# [002] * * #q#.# deletion syndrome . chromosome #q#.# [001] . chromosome #q#.# [002] . chromosome #q#.# deletion *

Related by context. All words. (Click for frequent words.) 77 #p#.# [002] 77 #q# [001] 75 #p#.# [001] 75 #p# [001] 73 #q#.# [002] 73 missense mutations 73 PTPN# 73 chromosome #q# [002] 72 #q# [002] 72 chromosome #q# [001] 71 microdeletions 71 CDKN2A 71 MLH1 71 chromosome #p# [001] 71 de novo mutations 70 #p# [003] 70 Clusterin 70 functional polymorphism 70 aneuploidies 70 chromosome #q#.# [001] 70 TCF#L# gene 69 TCF#L# 69 susceptibility gene 69 chromosome #p#.# 69 CDH1 69 SHANK3 69 Leukemias 69 rs# [002] 69 susceptibility locus 69 MLL2 68 rs# [004] 68 GSTP1 68 SNP rs# [001] 68 rs# [001] 68 heterozygosity 68 Chromosomal 68 MYH9 gene 68 dysbindin 68 GNAQ 68 germline mutations 68 MECP2 gene 67 IgA deficiency 67 microdeletion 67 hypermethylated 67 somatic mutation 67 microRNA expression 67 KIF6 gene 67 UGT#B# 67 chromosome #q#.# [002] 67 MSH2 67 NFKBIA 67 CNTNAP2 67 ABCB1 67 APOE e4 67 homozygosity 67 gastric carcinoma 67 inherited mutations 67 somatic mutations 67 monogenic 67 IL#R 67 variant allele 67 MTHFR 67 VNTR 67 ADPKD 67 methylenetetrahydrofolate reductase 67 susceptibility loci 67 catechol O methyltransferase 67 #S rRNA 67 TP# mutations 67 Polymorphisms 67 KRAS oncogene 67 genetic loci 67 BRCA1 BRCA2 67 K ras mutations 66 gene locus 66 Dysregulation 66 5q 66 CCR5 delta# 66 mosaicism 66 FGFR2 66 caveolin 66 Genotypes 66 missense mutation 66 genetic polymorphism 66 PARP inhibition 66 SLITRK1 66 NR#A# 66 CHD7 66 intronic 66 LRP5 66 chromosome #q 66 COL#A# 66 ERBB2 66 R#W [002] 66 inducible nitric oxide synthase 66 gene polymorphism 66 ZNF# 66 JAK2 enzyme 66 hypermethylation 66 cyclin E 66 DQB1 * 66 autosomal recessive 66 V#F mutation 66 NF1 gene 66 Polymorphism 66 chromosomal aberrations 66 ERK signaling 66 progressive neurodegenerative disorder 66 ADAMTS# 66 etiologic 66 CALHM1 66 MAPK pathway 65 Cytogenetic 65 virulence genes 65 myeloproliferative neoplasms 65 UGT#A# * 65 promoter methylation 65 5 HTTLPR 65 TTR gene 65 allelic variants 65 KCNH2 65 allelic 65 genomic deletions 65 paragangliomas 65 Prox1 65 EGFR gene 65 heterozygotes 65 TOP2A 65 IRF6 65 histone acetylation 65 Hashimoto thyroiditis 65 LRRK2 gene 65 chromosomal rearrangement 65 CHEK2 65 Subtypes 65 miRNA genes 65 apoE4 65 chromosome deletion 65 CYP#C# [002] 65 SMAD4 65 Phosphorylation 65 TSC1 65 susceptibility genes 65 sequence homology 65 demyelinating 65 serine protease 65 Plasmodium vivax 65 PTEN gene 65 neurofibromatosis type 64 ribosomal protein 64 von Hippel Lindau 64 FMR1 64 autosomal dominant disorder 64 Fas ligand 64 BRAF V#E 64 IKZF1 64 TOP2A gene 64 ataxias 64 Genetic Variation 64 mRNA transcripts 64 splice junctions 64 microsatellite instability 64 promoter hypermethylation 64 chromosomal regions 64 KIAA# 64 hepatic lipase 64 HFE gene 64 ALK gene 64 ORMDL3 64 BARD1 64 gene MECP2 64 microcephalin 64 FLT3 64 BMPR2 64 SPINK1 64 proband 64 Alleles 64 FMR1 gene 64 TYMS 64 alpha synuclein gene 64 rs# [003] 64 LRAT 64 Upregulation 64 sCJD 64 Epidermal Growth Factor Receptor 64 ABCB1 gene 64 Germline 64 cytogenetic abnormalities 64 Factor Receptor 64 proto oncogene 64 Methylation 64 Ischemic 64 p tau 64 autosomal 64 CYP#A# [002] 64 Histologic 64 Genetic variation 64 mediated inhibition 64 cell adhesion molecule 64 hamartomas 64 KCNE2 64 monozygotic twins 64 chromosomal deletions 64 gene amplification 64 MGUS 64 paraneoplastic 64 cytochrome b 64 dopamine receptor gene 64 Lymphocytic 64 C#Y 64 epigenetic alterations 63 FUS1 63 myopathies 63 apolipoprotein E 63 apolipoprotein E4 63 BDNF gene 63 colorectal carcinoma 63 gene rearrangements 63 deacetylation 63 BCL#A 63 Inactivation 63 Macrophage 63 BRAF gene 63 variant alleles 63 p# biomarker 63 methyltransferase 63 pT2 63 GSTM1 63 CYP#D# gene 63 #q# deletion 63 immunohistochemical 63 chromosome #p# [002] 63 osteoprotegerin 63 LPA gene 63 complement inhibitor eculizumab 63 variant rs# 63 TMPRSS2 ERG fusion 63 metalloprotease 63 PDGFR 63 NOD2 63 Tumor Suppressor 63 ALK mutations 63 H#K#me# 63 breast carcinomas 63 SLC#A# [002] 63 Estrogen Receptor 63 indels 63 sporadic ALS 63 K#R [002] 63 Genetic variants 63 immunoreactivity 63 protein encoded 63 p# mutations 63 Epstein Barr Virus 63 clinicopathological 63 COX2 63 Microarray analysis 63 Papillary 63 SNP rs# [002] 63 allele frequencies 63 MeCP2 gene 63 catechol O methyltransferase COMT 63 CYP#B# 63 breast cancer genes BRCA1 63 MYBPC3 63 SLC#A# [001] 63 HER2 overexpression 63 VEGF receptor 63 Janus kinase 63 RRM1 63 rs# rs# 63 TMEM#B 63 #q# deletion syndrome 63 APOE4 63 Sjögren syndrome 63 PALB2 63 SNCA 63 CNTNAP2 gene 63 MYCN amplification 63 gene polymorphisms 63 germline mutation 63 gastric carcinogenesis 63 3'UTR 63 lymphocytic 63 γ secretase 63 proapoptotic 63 protein tyrosine phosphatase 63 chromosomal instability 63 IDH1 mutation 63 Malignancies 63 HLA DRB1 * 63 PDGFRA 63 synuclein 63 number variation CNV 63 PON1 63 ApoE gene 63 CREBBP 63 epigenetic modification 63 neuronal dysfunction 63 ERalpha 63 NQO1 63 autoimmune thyroid 63 SCN5A 63 Apolipoprotein E 63 GBA mutations 63 hepatocellular carcinomas 63 mucinous 63 mRNA expression 63 RNase L 63 mesotheliomas 63 astrocytomas 63 TP# gene 63 thyrotropin 63 CNVs 63 CIN2 + 63 HNPCC 63 malignant neoplasm 63 Li Fraumeni syndrome 63 Adenoma 63 constitutively expressed 63 genetic polymorphisms 63 KLF4 63 succinate dehydrogenase 63 HOTAIR 63 EoE 63 FTLD 63 apoE 62 gene APOE 62 BMP2 62 Dystrophin 62 TIMP 1 62 Cyclin D1 62 methylation patterns 62 quantitative trait loci 62 karyotypes 62 miR #a [001] 62 androgen receptor AR 62 Predisposition 62 cytokeratin 62 polygenic 62 Brugada syndrome 62 Gene Mutation 62 WNK1 62 Premature Aging 62 miRNA expression 62 unknown etiology 62 SSc 62 circadian genes 62 adenocarcinomas 62 IGFBP2 62 ESR1 62 causative mutations 62 Heterogeneity 62 Transcriptome 62 CDK4 62 neoplastic 62 PIK3CA 62 Immunohistochemical analysis 62 VHL gene 62 orthologs 62 MEF2A 62 HLA DRB1 62 APOA5 62 testicular germ cell 62 receptor tyrosine kinase 62 mtDNA mutations 62 SCN1A 62 dopamine D4 receptor 62 HER2 expression 62 E#F# 62 segmental duplications 62 Subtype 62 chromosomal translocations 62 transgene expression 62 node metastases 62 breast carcinoma 62 dominantly inherited 62 single nucleotide polymorphism 62 WT1 62 histologic subtype 62 nephronophthisis 62 TGFBR1 * 6A 62 paraganglioma 62 ADH1B * 62 Mouse Model 62 Brain derived neurotrophic 62 TIMP 62 pathogenic mutations 62 Trichophyton rubrum 62 hyperinsulinemia 62 motor neuron degeneration 62 hepatoma 62 karyotype 62 APOL1 62 Squamous 62 CD8 + 62 SOD2 62 neuritic 62 paralogs 62 ribosomal DNA 62 familial ALS 62 Epstein Barr Virus EBV 62 hyperplastic 62 extramedullary 62 Oncogenic 62 antiphospholipid syndrome 62 Treg cell 62 Adenomas 62 GSTT1 62 PEDF 62 qRT PCR 62 cisplatin resistant 62 KRAS mutations 62 cagA 62 ependymomas 62 haematopoietic 62 CD#b 62 Dehydrogenase 62 TMPRSS2 ERG 62 IL 1ß 62 T1DM 62 upregulates 62 CpG island 62 apolipoprotein E APOE 62 thyroid carcinoma 62 monoclonal gammopathy 62 Overexpression 62 DNA methyltransferase 62 transcriptional silencing 62 CP CPPS 62 MMP# 62 alpha synuclein protein 62 polymorphisms 62 tryptophan hydroxylase 62 cAMP signaling 62 invasive ductal 62 cystic fibrosis transmembrane conductance 62 genes BRCA1 62 immunoblotting 62 IgG1 62 Entamoeba histolytica 62 apolipoprotein E gene 62 pheochromocytoma 62 Chromosome 62 ERK1 2 62 hypoperfusion 62 metachronous 62 HLA DR4 62 microglial activation 62 Cryptococcus neoformans 62 Myeloid 62 HepG2 cells 62 HLA DR 62 ß catenin 62 familial pancreatic cancer 62 Transcriptional 62 familial aggregation 62 aneuploidy 62 GPC5 62 HGPIN 62 Modulates 62 haplotypes 62 euthymic patients 62 genes encoding 62 MYH9 62 gastrointestinal stromal tumors GISTs 62 HNSCC 62 essential thrombocythemia 62 homozygotes 62 myeloperoxidase 62 mitochondrial DNA mtDNA 62 anaplastic lymphoma kinase ALK 61 MDR1 61 ectopic expression 61 mutated K ras 61 Kir#.# 61 OPRM1 61 HMGA2 61 IL#B 61 G6PD deficiency 61 fronto temporal dementia 61 myelofibrosis polycythemia vera 61 VIPR2 61 transmembrane receptor 61 MTHFR gene 61 Asymptomatic 61 vimentin 61 PON1 gene 61 maternally inherited 61 genetic variants associated 61 Phenotypic 61 Interferon Beta 61 Fibrosis 61 SGPT 61 breast cancer subtypes 61 mitochondrial gene 61 downregulation 61 miRs 61 PCa 61 cis regulatory 61 autosomal dominant 61 hyperhomocysteinemia 61 epithelial tumors 61 Metastases 61 immunodeficiencies 61 airway hyperresponsiveness 61 APOE ε4 61 uPAR 61 myeloproliferative 61 CYP#A# gene 61 SOD1 gene 61 oligodendrogliomas 61 hereditary hemochromatosis 61 c KIT 61 histologic subtypes 61 differential gene expression 61 intergenic 61 eotaxin 61 virus XMRV 61 inherited neurological disorder 61 adipogenic 61 Signaling Pathway 61 nonhereditary 61 periventricular 61 C. neoformans 61 matrix metalloproteinase 61 JAK mutations 61 genes differentially expressed 61 D#N 61 diagnostic biomarker 61 urothelial carcinoma 61 atypical hyperplasia 61 STAT4 61 prostate cancer CaP 61 renal fibrosis 61 glutamic acid decarboxylase 61 LKB1 61 TNF α 61 ETV1 61 progranulin gene 61 Mitochondrial 61 thiopurine 61 Immunohistochemical staining 61 autosomal recessive genetic 61 Philadelphia Chromosome Positive 61 OGG1 61 genomic rearrangement 61 phosphatidylinositol 3 61 Hutchinson Gilford progeria 61 coinfection 61 β1 61 LRP6 61 FOXP3 61 activating mutations 61 CagA 61 leiomyomas 61 p# activation 61 medulloblastomas 61 RUNX3 61 heterozygous 61 CHD5 61 miR #b [001] 61 papillary renal cell carcinoma 61 epigenetic markers 61 Wnt signaling pathway 61 mitochondrial disorders 61 PRNP 61 mitogen activated protein kinase 61 E cadherin expression 61 TP# mutation 61 herpesviruses 61 Smad3 61 EGFR HER2 61 endophenotypes 61 microglial 61 p# mutation 61 glycogen synthase kinase 61 PB1 F2 61 p# MAPK 61 PTEN mutations 61 FHIT 61 childhood leukemias 61 chemokine receptor 61 ORFs 61 TRAIL R1 61 nondemented 61 genomic instability 61 ABL1 61 genomewide 61 #S rRNA gene 61 autonomic dysfunction 61 HbF 61 modifier genes 61 activating mutation 61 pDC 61 phospholipase A2 61 Single Nucleotide Polymorphisms 61 Pten 61 invasive lobular 61 Apc 61 PTP1B 61 ependymoma 61 KCNQ1 61 Hurthle cell 61 thyrotropin levels 61 Eg5 61 inactivating mutations 61 seminomas 61 protein kinase C 61 dopamine transporter gene 61 histologic 61 tumor suppressor gene 61 Binding Protein 61 PLA2 61 affective psychosis 61 gene loci 61 malignant lymphoma 61 Supplementary Table 61 K#N 61 BRAF protein 61 hypomethylation 61 T#M 61 malignant lymphomas 61 NKX2 61 neurodevelopmental disorder 61 Protein Kinase C 61 Leydig cell 61 TAp# 61 gastric adenocarcinoma 61 immunoreactive 61 MAP#K# 61 proteolytic cleavage 61 familial clustering 61 splice variants 61 parkinsonism 61 post transplant lymphoproliferative 61 ADAM# 61 aldehyde dehydrogenase 61 Glioma 61 enterocolitis 61 MC4R gene 61 Activating mutations 61 AMACR 61 autosomal recessive disorder 61 Monocyte 61 VKORC1 61 neuropsychiatric diseases 61 phenotypic variation 61 aminotransferase 61 Genetic Mutation 61 Chlamydia pneumoniae 61 WDR# 61 Tumor Suppressor Gene 61 TT genotype 61 causal variants 61 mutant allele 61 IDH1 61 carcinoembryonic antigen 61 spontaneous mutation 61 adenylate cyclase 61 familial adenomatous polyposis 60 ApoE 60 alternatively spliced 60 PIGF 60 subcellular localization 60 pilocytic astrocytomas 60 Alzheimer Disease AD 60 #beta HSD1 60 tumorigenicity 60 spontaneous mutations 60 SOCS3 60 mRNA decay 60 CYP#A# CYP#D# 60 HLA DR4 immune 60 T#I [002] 60 #F FDG PET 60 prothrombotic 60 Immune Responses 60 HLA B# 60 murine leukemia virus 60 SCD1 60 serum BDNF 60 MLL gene 60 Heritability 60 mGluR 60 CYP #D# 60 CCL#L# 60 CYP# [002] 60 penetrance 60 DRD4 60 HLA DQ2 60 IL8 60 Autoimmune Disorders 60 chromosomal anomalies 60 LIS1 60 generalized vitiligo 60 IRAK1 60 erythematosus 60 autoantibody 60 Wwox 60 Trypanosoma brucei 60 receptor gene 60 primary hyperparathyroidism 60 Progenitor Cells 60 CHI#L# 60 esophageal squamous cell carcinoma 60 FGFR1 60 polymorphism 60 1 diabetes T1D 60 trinucleotide 60 LMNA 60 hypometabolism 60 tryptase 60 allelic variation 60 indel 60 SORL1 60 Cholangiocarcinoma 60 EBV infection 60 Nf1 60 TET2 60 myeloproliferative diseases 60 Carcinomas 60 cyclin dependent kinase 60 Genotype 60 IgG4 60 clinicopathologic 60 genetic syndromes 60 evolutionarily conserved 60 neuropathological 60 renal cysts 60 neoplasias 60 basal forebrain 60 interleukin IL -6 60 FGFR3 60 Neuronal 60 sporadic Creutzfeldt Jakob 60 SHANK3 gene 60 Bcl XL 60 leptin receptor 60 steroidogenic 60 PTEN protein 60 intron 60 noncoding 60 extracellular signal 60 myeloid 60 mutations 60 catenin 60 IDH1 gene 60 epigenetic silencing 60 tics involuntary 60 CC genotype 60 chromosome abnormality 60 sarcomatoid 60 Genetic variations 60 PAX5 60 Li Fraumeni 60 missense 60 nonsense mutations 60 NKX#.# 60 autism susceptibility genes 60 Metabolites 60 serine threonine kinase 60 globin genes 60 NF2 60 haplotype 60 human leukocyte antigen 60 N. gonorrhoeae 60 colorectal adenoma 60 seropositivity 60 hypothalamic pituitary 60 peroxisomal 60 FGFR2 gene 60 transcriptional regulation 60 upregulating 60 orthologous 60 polyadenylation 60 hematopoietic cancers 60 impaired glucose metabolism 60 G#S mutation 60 Haptoglobin 60 Interferon gamma 60 hereditary predisposition 60 linkage disequilibrium 60 beta1 integrin 60 transgenic mouse models 60 YKL 60 clusterin 60 phylogenetic analyzes 60 APOE gene 60 Oncogene 60 neoplasms 60 phosphorylated tau 60 predisposing factor 60 phosphorylates 60 lymphangiogenesis 60 hydroxylase 60 neuroblastomas 60 DLC1 60 myo inositol 60 NF1 60 aggrecan 60 transcriptional profiles 60 forkhead 60 E selectin 60 amyloid deposition 60 splenocytes 60 p# tumor suppressor 60 advanced adenoma 60 Alkaline Phosphatase 60 MELAS 60 neuroblastoma tumors 60 Histone 60 Supplemental Figure 60 aberrant methylation 60 amino terminal 60 pulmonary metastases 60 neuropsychiatric disorder 60 lysosomal storage disease 60 pancreatic endocrine 60 atrophic gastritis 60 nasopharyngeal carcinoma 60 polyglutamine 60 transcriptional repression 60 Subgroup analysis 60 haematologic 60 NAT2 60 cyclooxygenase 2 60 retinoic acid receptor 60 HIF 1alpha 60 CFTR gene 60 pancreatic prostate 60 normal karyotype 60 Jhdm2a 60 androgen receptor gene 60 genes CYP#C# 60 insertions deletions 60 Hippocampal 60 transcriptional repressor 60 Protein Kinase 60 Transgenic Mice 60 methicillin susceptible Staphylococcus aureus 60 Escherichia coli Klebsiella pneumoniae 60 PICALM 60 CTEPH 60 Mendelian disorders 60 alleles 60 malignant transformation 60 Chemokine Receptor 60 hypothalamic pituitary adrenal axis 60 Mitotic 60 hippocampal atrophy 60 PKC isoforms 60 Epstein Barr virus EBV 60 Dilated Cardiomyopathy 60 B7 H3 60 leukocyte adhesion 60 sphingolipid 60 Notch1 60 lymph node metastasis 60 C. trachomatis 60 prostate carcinoma 60 ERCC1 60 Phenotypes 60 B Raf 60 NFkappaB 60 aplasia 60 differentially expressed genes 60 hyper IgE syndrome 60 Nonalcoholic Fatty Liver Disease 60 DRD2 60 multivariable analysis 60 Parkinson Disease PD 60 genotoxic stress 60 hypovitaminosis D 60 Glycosylation 60 genetic determinants 60 HBeAg 60 Cholinesterase Inhibitors 60 Gene Mutations 60 cyclin dependent kinase inhibitor 60 PCA3 gene 60 serotonin receptor 60 polyposis 60 Cytotoxic T 60 mutated BRCA1 60 Cancer Incidence Mortality 60 human leukocyte antigen HLA 60 IRS1 60 Enzastaurin 60 SETDB1 59 Brugada Syndrome 59 hepatic enzymes 59 monocytic 59 Morphological 59 APOE genotype 59 cytopathic 59 precursor lesions 59 frameshift mutation 59 Fibroblast 59 inherited genetic mutations 59 IL 1β 59 elevated triglyceride levels 59 CCR9 59 #beta hydroxysteroid dehydrogenase 59 Mycoplasma pneumoniae 59 hormone receptor negative 59 circulating endothelial cells 59 MALT lymphoma 59 COMT gene 59 pathogenetic 59 mediated apoptosis 59 hyperprolactinemia 59 oxysterols 59 DNA methylation patterns 59 neurite outgrowth 59 neurological manifestations 59 gene APOE4 59 histone deacetylase 59 S#A# [002] 59 cause cardiac channelopathies 59 lung adenocarcinomas 59 5 hydroxytryptamine 59 mutant huntingtin protein 59 PCNSL 59 parkin gene 59 chitinase 59 downregulated 59 neuroligins 59 Arabidopsis genome 59 Cathepsin B 59 hyperparathyroidism 59 TOMM# 59 genetic heterogeneity 59 homeobox gene 59 ALDH2 59 chromosome rearrangements 59 FXTAS 59 idiopathic myelofibrosis 59 Gene Linked 59 systemic amyloidosis 59 TEAEs 59 Neuroprotection 59 dorsal root ganglion 59 NNRTI resistance 59 G6PD 59 gene BRCA2 59 non coding RNA 59 ductal lobular 59 demyelinating disease 59 abdominal adiposity 59 DRB1 * 59 downstream effector 59 plasminogen activator inhibitor 59 arrhythmogenic 59 previously undescribed 59 LPS induced 59 phosphoprotein 59 BRAF mutations 59 PCSK9 gene 59 gefitinib Iressa 59 proximal colon 59 grade cervical intraepithelial 59 replicon 59 distant metastasis 59 microsatellite markers 59 enteroviral 59 chromosomal rearrangements 59 constitutively active 59 mice lacking 59 Cytomegalovirus CMV 59 CDH# 59 PTEN tumor suppressor 59 B Cell Lymphoma 59 TNFalpha 59 prostate carcinogenesis 59 promoter polymorphism 59 ccRCC 59 deletion 5q 59 Neurofibromatosis Type 59 p#Kip# 59 acetylcholine receptor 59 Androgen 59 juvenile idiopathic arthritis JIA 59 clade B 59 #q#.# deletion syndrome 59 microRNAs miRNAs 59 Nocardia 59 choriocarcinoma 59 PNET 59 TTR amyloidosis 59 tumor suppressor protein 59 Heterozygous 59 Rap1 59 mPGES 1 59 P cadherin 59 choroidal neovascularization 59 MAOA gene 59 AML MDS 59 diabetes dyslipidemia

Back to home page